Giuseppe Curigliano

Associate Professor of Medical Oncology at the University of Milano and the Head of the Division of Early Drug Development at the European Institute of Oncology, Italy

Giuseppe Curigliano, MD PhD, is Associate Professor of Medical Oncology at the University of Milano and the Head of the Division of Early Drug Development at the European Institute of Oncology, Italy. He is a member of the Italian National Health Council since 2018 and, in 2019, he served as Chair of the Scientific Committee of The Lega Nazionale Lotta ai Tumori. He served on the Scientific Committee for the St Gallen Conference since 2011, and was the Scientific Co-Chair in St Gallen 2017, 2019 and 2021. He served as the Scientific Chair of the IMPAKT ESMO meeting that was held in Brussels in 2014 and as the Breast Cancer Track Chair of the ESMO 2014 meeting.

He served as Scientific Co-Chair of the ESMO Breast Cancer Congress in 2019, 2020 and 2021. He is an Editorial Board Member for Annals of Oncology, and serves as Co-Editor in Chief of The Breast, Co-Editor in Chief of Cancer Treatment Reviews, Associate Editor of the European Journal of Cancer, Editor of the Journal of Clinical Oncology.

Dr. Curigliano serves ESMO as Chair of the Guidelines Committee. He is the Chair of the ESMO Nomination Committee. He is member of the ESMO global Policy Committee and has been involved in the ESMO-WHO Cancer Workforce Project from 2019. He was awarded with the first ESO Umberto Veronesi Award in Vienna in 2017 and with the Fellowship of the European Academy of Cancer Sciences in Paris in 2017.He has contributed to over 440 peer-reviewed publications.

Updated: June 2021